Korea vs Western Pacific (WHO region): New cases tested for RR-/MDR-TB
Korea
100.0%
in 2024
Western Pacific (WHO region)
89.0%
in 2024
Korea rank
1st
Western Pacific (WHO region) rank
2nd
New cases tested for RR-/MDR-TB over time
- Korea
- Western Pacific (WHO region)
How they compare
Korea currently reports 100.0% against 89.0% in Western Pacific (WHO region), a difference of 11.0%.
That makes Korea's figure about 1.1 times Western Pacific (WHO region)'s.
Across all 13 years both countries report, Korea has been ahead every year.
Korea ranks 1st and Western Pacific (WHO region) ranks 2nd of 192 countries.
Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Korea | Western Pacific (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 78.6% | 28.9% | 49.8% | Korea |
| 2020s | 94.2% | 83.2% | 11.0% | Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Korea or Western Pacific (WHO region)?
- Korea, at 100.0% against 89.0% in Western Pacific (WHO region) as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Korea and Western Pacific (WHO region)?
- 11.0%, with Korea ahead.
- How many years of comparable data are there for Korea and Western Pacific (WHO region)?
- 13 years are reported by both, from 2011 to 2024.
- How do Korea and Western Pacific (WHO region) rank globally for new cases tested for rr-/mdr-tb?
- Korea ranks 1st and Western Pacific (WHO region) ranks 2nd of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.